Arcus Biosciences (RCUS) Property, Plant & Equipment (Net) Growth (1y) (2018 - 2026)
Arcus Biosciences (RCUS) Property, Plant & Equipment (Net) Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Arcus Biosciences | 3.57 Bn | 2.75 Bn | - | -17.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.39% |
| Dec 31, 2025 | -14.89% |
| Sep 30, 2025 | -12.50% |
| Jun 30, 2025 | -10.20% |
| Mar 31, 2025 | -9.80% |
| Dec 31, 2024 | -7.84% |
| Sep 30, 2024 | -4.00% |
| Jun 30, 2024 | 8.89% |
| Mar 31, 2024 | 37.84% |
| Dec 31, 2023 | 45.71% |
| Sep 30, 2023 | 47.53% |
| Jun 30, 2023 | 34.67% |
| Mar 31, 2023 | 10.51% |
| Dec 31, 2022 | 9.38% |
| Sep 30, 2022 | 17.61% |
| Jun 30, 2022 | 40.37% |
| Mar 31, 2022 | 125.48% |
| Dec 31, 2021 | 196.10% |
| Sep 30, 2021 | 230.18% |
| Jun 30, 2021 | 188.07% |